SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹206 Cr | ₹303 Cr | ₹348 Cr | ₹322 Cr | ₹320 Cr |
What is the latest Total Current Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹206 Cr |
Mar2023 | ₹303 Cr |
Mar2022 | ₹348 Cr |
Mar2021 | ₹322 Cr |
Mar2020 | ₹320 Cr |
How is Total Current Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹206 Cr | -32.01 | |
Mar2023 | ₹303 Cr | -12.79 | |
Mar2022 | ₹348 Cr | 8.09 | |
Mar2021 | ₹322 Cr | 0.52 | |
Mar2020 | ₹320 Cr | - |
Compare Total Current Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹39,097.9 Cr | 0.3% | 1.6% | 22% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 0.3% |
1.6% |
22% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses